SAN DIEGO: Alterome Therapeutics, Inc., a trailblazer in the biopharmaceutical industry, has successfully completed a Series B financing round, raising a substantial $132 million. This funding marks a pivotal step for the company as it aims to transition multiple innovative cancer treatments from the laboratory to clinical trials. “We are pleased with a financing of…
All posts tagged Series B
H2U raises over $10 million in Series B funding, aims to become Asia’s digital health unicorn
H2U, Taiwan’s leading digital health brand, announced that it has raised over 10 million USD in its Series B round of funding before the lunar new year. The round was led by Korea’s largest medical laboratory, Seoul Clinical Laboratories (SCL), and joined by Taiwan’s biggest food company, Standard Foods, the leading protein and antibody reagent…